Capital Fund Management (CFM)’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $465K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $446K | Sell |
|
|||||
|
2024
Q3 | $2.72M | Buy |
|
|||||
|
2024
Q2 | $1.53M | Buy |
|
|||||
|
2024
Q1 | $1.07M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $869K | Sell |
|
|||||
|
2023
Q2 | $1.19M | Buy |
|
|||||
|
2023
Q1 | $545K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.91M | Buy |
|
|||||
|
2021
Q4 | – | Hold |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $496K | Buy |
|